Evercore ISI Group Maintains Outperform on Edwards Lifesciences, Raises Price Target to $112

Benzinga · 3d ago
Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $102 to $112.